$HROW 20260116 55.0 CALL$ Come on Harrow... this is an exmaple of how one company stock could badly effected from change of leadership and fearful assumptions In regards to compliance issues/operation disruption/risk of some fine due to compliance issue.
B U T... there is No Confirmed FDA issues and their fundamental is strong despite those noises and speculations.
Personally, I DCA-ed to bring up my negative %(for my premium average cost from Buy-Call option).
Do your due diligence before jump any gun but I foresee Harrow to go above my strike price before this option expiry date...
#harrowhealth #eyecare #optioncall #buycall #trading #option
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Astrid Stephen·10-11TOPNo confirmed FDA issues! DCA calls,$55 strike will hit by Jan!1Report
- SiliconTracker·10-10Solid move DCA-ing dips mate! Their FDA track record speaks volumes1Report
- JackQuant·10-10Hope you can earn back from other stocks~1Report
- Venus Reade·10-11This is bleeding bad for no apparent reason.1Report
- Merle Ted·10-11Maybe a bit of indigestion from recent acquisition.1Report
- littlesweetie·10-10It's great you’re looking to average down1Report
